Vanguard Personalized Indexing Management
PFE icon

Vanguard Personalized Indexing Management’s Pfizer PFE Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
497,582
-100,965
-17% -$2.64M 0.1% 158
2026
Q1 		$16.8M Buy
598,547
+71,903
+14% +$1.91M 0.17% 98
2025
Q4 		$13.1M Sell
526,644
-14,735
-3% -$372K 0.13% 116
2025
Q3 		$13.8M Buy
541,379
+36,933
+7% +$912K 0.14% 112
2025
Q2 		$12.2M Buy
504,446
+105,453
+26% +$2.46M 0.14% 124
2025
Q1 		$10.1M Buy
398,993
+51,557
+15% +$1.35M 0.15% 113
2024
Q4 		$9.22M Sell
347,436
-81,402
-19% -$2.21M 0.14% 114
2024
Q3 		$12.4M Buy
428,838
+71,292
+20% +$2.08M 0.2% 81
2024
Q2 		$9.82M Buy
357,546
+47,785
+15% +$1.32M 0.19% 90
2024
Q1 		$8.6M Buy
309,761
+54,634
+21% +$1.52M 0.18% 89
2023
Q4 		$7.35M Sell
255,127
-54,090
-17% -$1.64M 0.19% 86
2023
Q3 		$10.3M Sell
309,217
-20,511
-6% -$725K 0.31% 46
2023
Q2 		$12.1M Buy
329,728
+1,414
+0.4% +$55K 0.37% 37
2023
Q1 		$13.4M Buy
328,314
+15,868
+5% +$685K 0.47% 31
2022
Q4 		$16M Buy
312,446
+28,055
+10% +$1.35M 0.66% 20
2022
Q3 		$12.4M Buy
284,391
+14,124
+5% +$686K 0.56% 22
2022
Q2 		$14.2M Buy
270,267
+68,866
+34% +$3.51M 0.66% 18
2022
Q1 		$10.4M Buy
201,401
+36,009
+22% +$1.87M 0.5% 22
2021
Q4 		$9.77M Buy
165,392
+57,040
+53% +$2.83M 0.58% 19
2021
Q3 		$4.66M Buy
108,352
+23,325
+27% +$1.03M 0.42% 36
2021
Q2 		$3.33M Buy
85,027
+25,455
+43% +$990K 0.35% 45
2021
Q1 		$2.16M Buy
59,572
+19,762
+50% +$702K 0.33% 55
2020
Q4 		$1.47M Buy
39,810
+3,009
+8% +$110K 0.32% 69
2020
Q3 		$1.28M Buy
36,801
+6,955
+23% +$244K 0.36% 60
2020
Q2 		$926K Buy
29,846
+3,635
+14% +$123K 0.42% 49
2020
Q1 		$812K Buy
+26,211
New +$893K 0.47% 53

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Personalized Indexing Management's PFE Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Pfizer (PFE) stake by 17% in Q2 2026, selling an estimated $2.64M and leaving 497,582 shares worth $12M. The position accounts for 0.1% of the portfolio, ranked #158.

Vanguard Personalized Indexing Management first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $16.8M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vanguard Personalized Indexing Management held 497,582 shares of Pfizer worth $12M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 100,965 Pfizer shares in Q2 2026, an estimated $2.64M.
  • Pfizer made up 0.1% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #158 holding.
  • Vanguard Personalized Indexing Management first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Vanguard Personalized Indexing Management's Pfizer position peaked at $16.8M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.